Boston Scientific Corp (NYSE:BSX)
| 44.37 Delayed Data As of 4:00pm ET |  -0.53 / -1.18%Today’s Change | 32.99 Today|||52-Week Range 46.29 | +23.42% Year-to-Date |
Latest BSX News | Press Releases
| Here's Why You Should Retain Boston Scientific (BSX) for Now Sep 10 / Zacks.com - Paid Partner Content | NVST vs. BSX: Which Stock Should Value Investors Buy Now? Sep 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 44.90 |
| Today’s open | 44.56 |
| Day’s range | 43.93 - 44.58 |
| Volume | 8,419,639 |
| Average volume (3 months) | 6,378,394 |
| Market cap | $63.3B |
Data as of 4:00pm ET, 09/17/2021
Growth & Valuation
| Earnings growth (last year) | -102.40% |
| Earnings growth (this year) | +67.68% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | -7.66% |
| P/E ratio | 118.9 |
| Price/Sales | 5.14 |
| Price/Book | 4.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DXCMDexcom Inc | -2.90 | -0.51% |
| BDXBecton Dickinson and... | -0.62 | -0.24% |
| BAXBaxter International... | +0.40 | +0.48% |
| WSTWest Pharmaceutical ... | -5.70 | -1.25% |
Data as of 4:00pm ET, 09/17/2021
Financials
| Next reporting date | October 27, 2021 |
| EPS forecast (this quarter) | $0.40 |
| Annual revenue (last year) | $9.9B |
| Annual profit (last year) | -$82.0M |
| Net profit margin | -0.83% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
